2-(Propylthio)-5-(trifluoromethyl)pyridin-3-ylboronic acid
- $75 - $395
- Product name: 2-(Propylthio)-5-(trifluoromethyl)pyridin-3-ylboronic acid
- CAS: 1256345-56-8
- MF: C9H11BF3NO2S
- MW: 265.06
- EINECS:
- MDL Number:MFCD16660276
- Synonyms:2-(Propylthio)-5-(trifluoromethyl)pyridin-3-ylboronic acid;2-Propylthio-5-trifluoromethylpyridine-3-boronic acid;Boronic acid, B-[2-(propylthio)-5-(trifluoromethyl)-3-pyridinyl]-
3 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 100mg
- 5g
- 10g
- ManufacturerAK Scientific
- Product numberX1806
- Product description2-Propylthio-5-trifluoromethylpyridine-3-boronicacid
- Packaging5g
- Price$371
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11314557
- Product description(2-(Propylthio)-5-(trifluoromethyl)pyridin-3-yl)boronicacid 95+%
- Packaging10g
- Price$395
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP838543
- Product description2-Propylthio-5-trifluoromethylpyridine-3-boronicAcid
- Packaging100mg
- Price$75
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | X1806 | 2-Propylthio-5-trifluoromethylpyridine-3-boronicacid | 5g | $371 | 2021-12-16 | Buy |
Crysdot | CD11314557 | (2-(Propylthio)-5-(trifluoromethyl)pyridin-3-yl)boronicacid 95+% | 10g | $395 | 2021-12-16 | Buy |
TRC | P838543 | 2-Propylthio-5-trifluoromethylpyridine-3-boronicAcid | 100mg | $75 | 2021-12-16 | Buy |
Properties
Boiling point :376.4±52.0 °C(Predicted)
Density :1.36±0.1 g/cm3(Predicted)
storage temp. :Refrigerated.
pka :5.79±0.53(Predicted)
Density :1.36±0.1 g/cm3(Predicted)
storage temp. :Refrigerated.
pka :5.79±0.53(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|